Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
Northwest Biotherapeutics' Chief Technical Officer Dr. Marnix Bosch will deliver an invited keynote at the UK NHS CancerCare Oncology Conference on October 6. The talk covers the new era of cancer vaccines and the company's DCVax platform, including clinical trial results and potential combination treatments; slides will be posted to the company website afterward.
Key figures
- Dcvax l phase3 patients
- 331
- Dcvax direct phase1 patients
- 40
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.